Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats
Patrick M. Callahan, Alvin V. Terry, Ashok Tehim
Psychopharmacology (2014) Vol. 231, Iss. 18, pp. 3695-3706
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Therapeutic Potential ofα7 Nicotinic Acetylcholine Receptors
Daniel Bertrand, Chih-Hung L. Lee, Dorothy G. Flood, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 4, pp. 1025-1073
Open Access | Times Cited: 130
The current agonists and positive allosteric modulators of α 7 nAChR for CNS indications in clinical trials
Taoyi Yang, Ting Xiao, Qi Sun, et al.
Acta Pharmaceutica Sinica B (2017) Vol. 7, Iss. 6, pp. 611-622
Open Access | Times Cited: 104
α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future
Alvin V. Terry, Patrick M. Callahan
Neuropharmacology (2020) Vol. 170, pp. 108053-108053
Open Access | Times Cited: 72
Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics
Daisy L. Spark, Alex Fornito, Christopher J. Langmead, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Relationships and Interactions between Ionotropic Glutamate Receptors and Nicotinic Receptors in the CNS
Trevor W. Stone
Neuroscience (2021) Vol. 468, pp. 321-365
Open Access | Times Cited: 38
3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats
Agnieszka Potasiewicz, Małgorzata Hołuj, Tomasz Kos, et al.
Neuropharmacology (2016) Vol. 113, pp. 188-197
Closed Access | Times Cited: 45
The Role of Nicotine in Schizophrenia
Robert E. Featherstone, Steven J. Siegel
International review of neurobiology (2015), pp. 23-78
Closed Access | Times Cited: 44
Tropisetron sensitizes α7 containing nicotinic receptors to low levels of acetylcholine in vitro and improves memory-related task performance in young and aged animals
Patrick M. Callahan, Daniel Bertrand, Sonia Bertrand, et al.
Neuropharmacology (2017) Vol. 117, pp. 422-433
Closed Access | Times Cited: 41
Cardioprotective role of GTS-21 by attenuating the TLR4/NF-κB pathway in streptozotocin-induced diabetic cardiomyopathy in rats
Mahmoud E. Youssef, Heba M. A. Abdelrazek, Yasser M. Moustafa
Naunyn-Schmiedeberg s Archives of Pharmacology (2020) Vol. 394, Iss. 1, pp. 11-31
Closed Access | Times Cited: 34
α7nAChR activation protects against oxidative stress, neuroinflammation and central insulin resistance in ICV-STZ induced sporadic Alzheimer's disease
P. Yamini, R. S. Ray, Sonal Yadav, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 217, pp. 173402-173402
Closed Access | Times Cited: 22
Kynurenine amplifies tetrahydrocannabinol-induced sensorimotor impairment and classic “tetrad” effects in mice
Sabrine Bilel, Giorgia Corli, Edoardo Tiziani, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111342-111342
Closed Access
Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders
Alvin V. Terry, Patrick M. Callahan, Caterina M. Hernandez
Biochemical Pharmacology (2015) Vol. 97, Iss. 4, pp. 388-398
Open Access | Times Cited: 39
Nicotinic α7 receptor activation selectively potentiates the function of NMDA receptors in glutamatergic terminals of the nucleus accumbens
Stefania Zappettini, Massimo Grilli, Guendalina Olivero, et al.
Frontiers in Cellular Neuroscience (2014) Vol. 8
Open Access | Times Cited: 38
Vortioxetine improved negative and cognitive symptoms of schizophrenia in subchronic MK-801 model in rats
Nuh Mehmet Bozkurt, Gökhan Ünal
Behavioural Brain Research (2023) Vol. 444, pp. 114365-114365
Closed Access | Times Cited: 10
R-(+) and S-(−) Isomers of Cotinine Augment Cholinergic Responses In Vitro and In Vivo
Alvin V. Terry, Patrick M. Callahan, Daniel Bertrand
Journal of Pharmacology and Experimental Therapeutics (2014) Vol. 352, Iss. 2, pp. 405-418
Open Access | Times Cited: 31
Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer’s Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study
Hana Florian, Andreas Meier, Serge Gauthier, et al.
Journal of Alzheimer s Disease (2016) Vol. 51, Iss. 4, pp. 1237-1247
Closed Access | Times Cited: 31
Pro‐cognitive activity in rats of 3‐furan‐2‐yl‐N‐p‐tolyl‐acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor
Agnieszka Potasiewicz, Tomasz Kos, Federica Ravazzini, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 21, pp. 5123-5135
Open Access | Times Cited: 29
Atypical visual and somatosensory adaptation in schizophrenia-spectrum disorders
Gizely N. Andrade, John S. Butler, Gregory A. Peters, et al.
Translational Psychiatry (2016) Vol. 6, Iss. 5, pp. e804-e804
Open Access | Times Cited: 27
Modulation of preeclampsia by the cholinergic anti-inflammatory pathway: Therapeutic perspectives
Abdalla M. Wedn, Hany M. El‐Bassossy, Ali H. Eid, et al.
Biochemical Pharmacology (2021) Vol. 192, pp. 114703-114703
Open Access | Times Cited: 21
Long-Term Effects of Prenatal Hypoxia on Schizophrenia-Like Phenotype in Heterozygous Reeler Mice
Kristy R. Howell, Anilkumar Pillai
Molecular Neurobiology (2015) Vol. 53, Iss. 5, pp. 3267-3276
Closed Access | Times Cited: 25
Differential effects of alkaloids on memory in rodents
Patrick M. Callahan, Alvin V. Terry, Manuel C. Peitsch, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Regulation of aggressive behaviors by nicotinic acetylcholine receptors: Animal models, human genetics, and clinical studies
Alan S. Lewis, Marina R. Picciotto
Neuropharmacology (2019) Vol. 167, pp. 107929-107929
Open Access | Times Cited: 18
Improved Outcomes of Cardiopulmonary Resuscitation in Rats Treated With Vagus Nerve Stimulation and Its Potential Mechanism
Peng Sun, Jiangang Wang, Shen Zhao, et al.
Shock (2017) Vol. 49, Iss. 6, pp. 698-703
Open Access | Times Cited: 18
Tropisetron enhances recognition memory in rats chronically treated with risperidone or quetiapine
Indrani Poddar, Patrick M. Callahan, Caterina M. Hernandez, et al.
Biochemical Pharmacology (2017) Vol. 151, pp. 180-187
Open Access | Times Cited: 17
α7 nicotinic receptor agonist and positive allosteric modulators differently improved schizophrenia-like cognitive deficits in male rats
Gökhan Ünal, Serap Şirvancı, Feyza Arıcıoğlu
Behavioural Brain Research (2020) Vol. 397, pp. 112946-112946
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top